Ixekizumab-induced urticaria is associated with the short duration of remission in psoriasis by activation of mast cells- Supplemental Data
Published: 15 January 2024| Version 1 | DOI: 10.17632/hdhg8byr9b.1
Contributors:
Li Zhang, , , , , , , , , , , Description
"Ixekizumab-induced urticaria is associated with the short duration of remission in psoriasis by activation of mast cells" Supplemental Data for JAAD Article
Files
Categories
Dermatology, Mast Cell, Psoriasis